3rd Quarter - Report

NATIONAL ASSOCIATION OF CHAIN DRUG STORES for NATIONAL ASSOCIATION OF CHAIN DRUG STORES

Firm
Client
Income
—
Expenses
$920,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

H.R.1735 - National Defense Authorization Act for Fiscal Year 2016 S. 1118 National Defense Authorization Act for Fiscal Year 2016

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
COLIN BRAINARD New —
HEIDI ANN ECKER —
ANNE FOLEY —
YVONNE HAMPEL —
CAROL KELLY —
KEVIN N NICHOLSON —
THOMAS ALFRED O'DONNELL —

Contacted: Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES

Bills named: S. 1118 (114th), H.R. 1735 (114th)

Budget/Appropriations BUD

H.R. 83: Consolidated and Further Continuing Appropriations Act, 2015

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
COLIN BRAINARD —
HEIDI ANN ECKER —
ANNE FOLEY —
YVONNE HAMPEL —
CAROL KELLY —
KEVIN N NICHOLSON —
THOMAS ALFRED O'DONNELL —

Contacted: Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Defense, Dept of (DOD); SENATE

Bills named: H.R. 83 (114th)

Pharmacy PHA

H.R.5194 - 114th Congress (2015-2016)Safe Drug Disposal Tax Credit Act of 2016

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
COLIN BRAINARD —
HEIDI ANN ECKER —
ANNE FOLEY —
YVONNE HAMPEL —
CAROL KELLY —
KEVIN N NICHOLSON —
THOMAS ALFRED O'DONNELL —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Defense, Dept of (DOD); Drug Enforcement Administration (DEA)

Bills named: H.R. 5194 (114th)

Alcohol and Drug Abuse ALC

H.R. 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.524 - Comprehensive Addiction and Recovery Act of 2016 H.R.953 - Comprehensive Addiction and Recovery Act of 2015 HR 3250 - DXM Abuse Prevention Act S. 2294 - DXM Abuse Prevention Act H.R. 5046 - Comprehensive Opioid Abuse Reduction Act of 2016 H.R.4931 - Pharmaceutical Stewardship Act of 2016 S. 3075 - Addiction Prevention and Responsible Opioid Practices Act

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
COLIN BRAINARD New —
HEIDI ANN ECKER —
ANNE FOLEY —
YVONNE HAMPEL —
CAROL KELLY —
KEVIN N NICHOLSON —
THOMAS ALFRED O'DONNELL —

Contacted: Food & Drug Administration (FDA); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3250 (114th), H.R. 5046 (114th), H.R. 4931 (114th), S. 3075 (114th), S. 2294 (114th), S. 524 (114th), S. 483 (114th), H.R. 471 (114th), H.R. 953 (114th)

Medicare/Medicaid MMM

S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act H.R. 1270 - Restoring Access to Medication Act of 2015 S. 709 - Restoring Access to Medication Act of 2015 S.776 - Medication Therapy Management Empowerment Act of 2015 H.R. 793 - Ensuring Seniors Access to Pharmacies Act of 2015 H.R. 1021, the Protecting the Integrity of Medicare Act (PIMA) of 2015 H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R.6 - 21st Century Cures Act S.1190 - Ensuring Seniors Access to Local Pharmacies Act of 2015 S. 1913 - Stopping Medication Abuse and Protecting Seniors Act of 2015 H.R.4878 - Better Care, Lower Cost Act S. 3094 - Price Relief, Innovation, and Competition for Essential Drugs Act HR 5573 - Price Relief, Innovation and Competition for Essential Drugs Act H. R. 4641 -To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes. HR 5210-Patient Access to Durable Medical Equipment Act S 2736-Patient Access to Durable Medical Equipment Act of 2016 H.R. 1192 - National Diabetes Clinical Care Commission Act S. 3056 - Creating and Restoring Equal Access to Equivalent Samples Act H.R. 5951- Improving Transparency and Accuracy in Medicare Part B Spending

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
COLIN BRAINARD —
HEIDI ANN ECKER —
ANNE FOLEY —
YVONNE HAMPEL New —
CAROL KELLY —
KEVIN N NICHOLSON —
THOMAS ALFRED O'DONNELL —

Contacted: Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA)

Bills named: H.R. 4878 (114th), S. 3056 (114th), S. 709 (114th), H.R. 4641 (114th), S. 1190 (114th), H.R. 1192 (114th), H.R. 5210 (114th), S. 3094 (114th), S. 314 (114th), H.R. 793 (114th), S. 1913 (114th), H.R. 1021 (114th), H.R. 2 (114th), H.R. 6 (114th), H.R. 1270 (114th), S. 776 (114th), H.R. 5573 (114th), H.R. 5951 (114th), H.R. 592 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.